Developing story — details emerging. Check the source link for the latest updates.
Source: [Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/brian-niccol-turnaround-working-starbucks-114522068.html)
Developing story — details emerging. Check the source link for the latest updates.
Lilly’s sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.